Samir Mitragotri
Overview
Explore the profile of Samir Mitragotri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
309
Citations
14209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumbhojkar N, Mitragotri S
Bioeng Transl Med
. 2025 Jan;
10(1):e10704.
PMID: 39801751
Cell therapies are at the forefront of novel therapeutics. Neutrophils, despite being the most populous immune cells in human blood circulation, are not considered a viable option for cellular therapies...
2.
Fukuta T, Kumbhojkar N, Prakash S, Shaha S, Silva-Candal A, Park K, et al.
Bioeng Transl Med
. 2025 Jan;
10(1):e10712.
PMID: 39801750
Immune checkpoint inhibitors (ICIs) represent new therapeutic candidates against glioblastoma multiforme (GBM); however, their efficacy is clinically limited due to both local and systemic immunosuppressive environments. Hence, therapeutic approaches that...
3.
Janes M, Gottlieb A, Park K, Acharya S, Bibbey M, Mitragotri S
J Control Release
. 2024 Dec;
379:135-146.
PMID: 39733913
Despite the success of global vaccination campaigns, vaccine access in low-resource settings is an ongoing challenge. Subunit vaccines are a well-established and clinically scalable intervention, yet they have achieved limited...
4.
Nakajima M, Kapate N, Clegg J, Ikeda-Imafuku M, Park K, Kumbhojkar N, et al.
J Control Release
. 2024 Nov;
377:315-323.
PMID: 39561948
Cell immunotherapy is a promising therapeutic modality to combat unmet medical needs. Macrophages offer a prominent cell therapy modality since their phenotypic plasticity allows them to perform a variety of...
5.
Joshi M, Zhao Z, Mitragotri S
Bioeng Transl Med
. 2024 Nov;
9(6):e10673.
PMID: 39545083
Given the prevalence of hematological conditions, surgeries, and trauma incidents, hemostats-therapeutics designed to control and arrest bleeding-are an important tool in patient care. The prophylactic and therapeutic use of hemostats...
6.
Clegg J, Adebowale K, Zhao Z, Mitragotri S
Bioeng Transl Med
. 2024 Nov;
9(6):e10680.
PMID: 39545079
Hydrogels have been used in the clinic since the late 1980s with broad applications in drug delivery, cosmetics, tissue regeneration, among many other areas. The past three decades have witnessed...
7.
Udofa E, Sankholkar D, Mitragotri S, Zhao Z
Bioeng Transl Med
. 2024 Nov;
9(6):e10677.
PMID: 39545074
Antibody-drug conjugates (ADCs), chemotherapeutic agents conjugated to an antibody to enhance their targeted delivery to tumors, represent a significant advancement in cancer therapy. ADCs combine the precise targeting capabilities of...
8.
Goetz M, Park K, Joshi M, Gottlieb A, Dowling D, Mitragotri S
J Control Release
. 2024 Oct;
376:632-645.
PMID: 39437967
Vaccination is an important strategy for the prevention of infectious diseases worldwide. Adjuvants can be incorporated in vaccine formulations to enhance the resultant immune response and subsequently confer more robust...
9.
Mitragotri S
J Control Release
. 2024 Oct;
376:593-600.
PMID: 39427776
Ionic liquids, organic salts in a liquid state below 100 °C, have traditionally been associated with industrial applications. Recent research has introduced a new generation of ionic liquids, designed from...
10.
Yan C, Nakajima M, Ikeda-Imafuku M, Yanagawa M, Hayatsu M, Fukuta T, et al.
Int J Pharm
. 2024 Aug;
662:124544.
PMID: 39094920
Periodontitis is a chronic inflammatory disease that causes destruction of the periodontium and eventual tooth loss. The priority in the periodontal treatment is to remove the subgingival biofilm. Chemical removal...